TRUTAKNA
@trutakna.com
Learn more about TRUTAKNA, a new FDA-approved treatment. See Full Prescribing & Safety Information.
TRUTAKNA's Company Logos
TRUTAKNA's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#36508C
Chambray
54, 80, 140
222, 44, 38
61, 43, 0, 45
#111C2C
Big Stone
17, 28, 44
216, 44, 12
61, 36, 0, 83
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About TRUTAKNA
IgA Nephropathy (IgAN) is a rare autoimmune kidney disease characterized by the production of abnormal antibodies that form immune clusters, leading to kidney damage. The disease can result in serious consequences, including proteinuria (excess protein in urine), hematuria (blood in urine), and declining kidney function. Symptoms may vary, with some individuals experiencing fatigue and swelling while others remain asymptomatic.
TRUTAKNA (atacicept-vymj) is a prescribed medication specifically designed for adults with IgAN, aimed at reducing protein levels in urine and slowing disease progression. It is tailored for patients at risk of worsening kidney function. The treatment requires careful consideration of safety information, including potential allergic reactions and immunosuppression risks.
IgAN and treatment strategies are continuously evaluated to ensure they meet the needs of those affected, providing comprehensive resources and support to enhance patient understanding of managing this chronic condition
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
